Ergotamine Tartrate
Spécifications
379-79-3Numéro CAS
206-835-9Numéro CE
bis((6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide);(2R,3R)-2,3-dihydroxybutanedioic acidNom IUPAC
C70H76N10O16Formule chimique
1313.4 g/molMasse molaire
ergotamine tartrate; Ergotamine D-tartrate; 379-79-3; Lingraine; Wigrettes; Ergostat; Gotamine tartrate; Medihaler ergotamine; Ergotamine bitartrate; Exmigra; Femergin; Lingran; Secagyn; Secupan; Ergate; Neo-ergotin; Rigetamin; DTXSID3025253; MRU5XH3B48; Ergotamini tartras; DTXCID605253; ETIN; Ergotamine, tartrate (2:1) (salt); NSC-41869; Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt); Ergomar Sublingual; Tartrate, Ergotamine; NSC41869; RefChem:55122; Ergotamine Tartrate (2:1); (5'S)-5'-Benzyl-12'-hydroxy-2'-methylergotaman-3',6',18-trione hemitartrate; 206-835-9; Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-,(5'alpha)-,(2R,3R)-2,3-dihydroxybutanedioate(2:1)(salt); Ergomar; Gynergen; Cornutamin; Migretamine; Avetol; Ergam; Ergotamine hemitartrate; Ergotartrate; Ergomar (TN); Ergotamine, tartrate (2:1); CAS-379-79-3; NCGC00091935-01; Ergotamine tartrate (VAN); UNII-MRU5XH3B48; CCRIS 487; Ergotamine tartrate [USP:JAN]; EINECS 206-835-9; Ergotamine tartrate (2:1) (salt); NSC 41869; Ergotamine tartrate RS - *; ERGOTAMINE TARTRATE [MI]; DEA NO. 8676 (Tartrate); ERGOTAMINE TARTRATE [JAN]; CJMJLDQKTOJACI-BGQAIRJTSA-N; Ergotamine tartrate (JP18/USP); Ergotamine tartrate [EP monograph]; ERGOTAMINE TARTRATE [VANDF]; ERGOTAMINE TARTRATE [MART.]; Tox21_111183; Tox21_201705; Tox21_303182; C70H76N10O16; ERGOTAMINE TARTRATE [USP-RS]; ERGOTAMINE TARTRATE [WHO-DD]; ERGOTAMINE TARTRATE [WHO-IP]; FE30656; ERGOTAMINE TARTRATE [ORANGE BOOK]; NCGC00257225-01; NCGC00259254-01; ERGOTAMINE TARTRATE [USP IMPURITY]; ERGOTAMINI TARTRAS [WHO-IP LATIN]; ERGOTAMINE TARTRATE [USP MONOGRAPH]; CAFERGOT COMPONENT ERGOTAMINE TARTRATE; Ergotamine tartrate CRS - * Drug Precursor; MIGERGOT COMPONENT ERGOTAMINE TARTRATE; WIGRAINE COMPONENT ERGOTAMINE TARTRATE; D00679; Ergotamine For System Suitability CRS - * Drug Prec; Q27284199; Ergotamine tartrate, European Pharmacopoeia (EP) Reference Standard; (2R,3R)-2,3-Dihydroxybutanedioic acid--5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman (1/2); (6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2R,3R)-2,3-dihydroxybutanedioic acid; ERGOTAMAN-3',6',18-TRIONE, 12'-HYDROXY-2'-METHYL-5'-(PHENYLMETHYL)-, (5'.ALPHA.)-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (2:1) (SALT); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1); Ergotamine tartrate, United States Pharmacopeia (USP) Reference Standard, monograph mol wt. 1313.41 ((C33H35N5O5)2 ?? C4H6O6)Synonymes
Produits contenant Ergotamine Tartrate
Entreprises vendant Ergotamine Tartrate
지엘
지엘팜텍(주)Republic of Korea日医
日医工株式会社Japan명인
명인제약(주)Republic of KoreaPC
Pharmix CorporationRepublic of KoreaCT
Công ty cổ phần dược phẩm OsakaViet NamAM
AMDIPHARMFranceAL
Amdipharm LimitedSpainDL
Desma Laboratorio Farmaceutico S.L.SpainBD
Biotechnica DWCAlgeriaTT
TAPI Technology & API ServicesIsrael